Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksArcontech Group Regulatory News (ARC)

Share Price Information for Arcontech Group (ARC)

Share Price is delayed by 15 minutes
Get Live Data
83.50    6.00 (7.74%)
Bid:
82.00
Ask:
85.00
Spread: 3.00 (3.659%)
Market Cap: £11.17m
ARC Live PriceLast checked at - London Stock Exchange

Intraday Arcontech Group Share Chart

Trading Statement

Today 07:00

RNS Number : 0392K
Arcontech Group PLC
29 June 2026
Β 

The information contained within this announcement is deemed to constitute inside information as stipulated under the Market Abuse Regulations (EU No. 596/2014) which is part of UK law by virtue of the European Union (Withdrawal) Act 2018. Upon the publication of this announcement, this inside information is now considered to be in the public domain.

ARCONTECH GROUP PLCΒ 

("Arcontech" or the "Company")

Client Win/Trading update

Arcontech (AIM: ARC), the provider of software products and services for the management of real-time financial market-data, is pleased to announce that it has secured a new contract for its CityVision real-time market data platform to enable multiple data sources to be consumed by various applications written in different programming languages.

Following a successful bidding process, Arcontech has signed a 3-year contract with a total value of approximately Β£800k with a major European bank for deployment of its software in various areas within its trading infrastructure. The contract is with a new customer and has strong expansion potential across the customer's wider market-data estate, with revenue recognition expected to commence in calendar Q3 2026.

As a vendor agnostic market data platform, Arcontech CityVision provides a cost-effective alternative to existing platforms and the flexibility to choose any source of data to avoid "vendor lock-in". Arcontech CityVision is relied upon by some of the largest global banks.

The Company would also like to advise that current performance for the full year ended 30 June 2026 for both revenue and profit is in line with market expectations.

Financial expectations noted above are preliminary and are subject to year-end and financial close and audit review processes.

Enquiries:

Arcontech Group plc 020 7256 2300

Geoff Wicks, Chairman and Non-Executive Director

Matthew Jeffs, Chief Executive

Cavendish Capital Markets Ltd (Nomad & Broker) 020 7220 0500

Jonny Franklin Adams/Isaac Hooper (Corporate Finance)

Harriet Ward (Corporate Broking)

To access more information on the Group please visit: www.arcontech.com

Β 

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
TSTBLGDLSXDDGLL
Date   Source Headline
20th Sep 20107:00 amRNSDirector/PDMR Shareholding
26th Jul 20107:00 amRNSPreliminary Results
14th Jun 20101:27 pmRNSHolding(s) in Company
16th Apr 20107:00 amRNSExcelerator Version 3 Release
15th Apr 20106:20 pmRNSHolding(s) in Company
26th Mar 20107:00 amRNSHalf Yearly Report
14th Dec 20097:00 amRNSNew Contract
11th Dec 20097:00 amRNSNew Director of Sales and Marketing
27th Nov 20097:00 amRNSNew Contract
9th Nov 200911:04 amRNSHolding(s) in Company
9th Nov 200910:55 amRNSHolding(s) in Company
4th Nov 200912:21 pmRNSHolding(s) in Company
29th Oct 20094:35 pmRNSResult of AGM
8th Oct 20098:31 amRNSHolding(s) in Company
6th Oct 20097:00 amRNSProduct Launch
21st Sep 20097:00 amRNSFinal Results
21st Sep 20097:00 amRNSPlacing to raise ?1.55 million
14th Jul 20097:00 amRNSIssue of Deferred Consideration
15th Jun 20097:00 amRNSChange of Name of Nominated Adviser and Broker
15th May 20097:00 amRNSStatement re CityVision
29th Apr 20097:00 amRNSArcontech's Excelerator finds favour in Europe
25th Mar 200912:38 pmRNSDirector/PDMR Shareholding
20th Mar 20097:00 amRNSHalf Yearly Report
23rd Feb 20097:00 amRNSChange of Name
28th Nov 20087:00 amRNSFinal Results
15th Sep 20087:00 amRNSStatement re Arcontech
22nd May 200812:30 pmRNSSale of MT Information Base
17th Apr 200811:47 amRNSHolding(s) in Company
15th Apr 20082:43 pmRNSHolding(s) in Company
10th Apr 200810:51 amRNSHolding(s) in Company
10th Apr 20087:00 amRNSDirector/PDMR Shareholding
4th Apr 20085:39 pmRNSDirector/PDMR Shareholding
4th Apr 20087:01 amRNSAdditional Listing
31st Mar 20087:02 amRNSInterim Results
11th Mar 20087:02 amRNSLaunch of New Website
3rd Mar 20087:02 amRNSExpansion of StarNet
17th Jan 20086:21 pmRNSRe Contract - Replacement
16th Jan 20087:01 amRNSRe Contract
18th Dec 20077:01 amRNSDirectorate Change
13th Dec 20079:48 amRNSHolding(s) in Company
10th Dec 200711:14 amRNSHolding(s) in Company
4th Dec 20077:01 amRNSFinal Results
20th Sep 20079:30 amRNSContract Win
5th Sep 20071:53 pmRNSHolding(s) in Company
3rd Sep 20072:11 pmRNSAdditional Listing
7th Aug 20077:01 amRNSAcquisition
19th Jul 20077:00 amRNSNew Best Execution Tool on MT
12th Jul 20079:54 amRNSStatement re Trading on PLUS
22nd Mar 20072:30 pmRNSHolding(s) in Company
12th Mar 20077:01 amRNSInterim Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.